The subtle side to hypoxia inducible factor (HIFα) regulation

被引:121
作者
Bilton, RL [1 ]
Booker, GW [1 ]
机构
[1] Univ Adelaide, Dept Mol Biosci, Adelaide, SA 5005, Australia
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2003年 / 270卷 / 05期
关键词
HIF alpha; growth factor; oncogene; PI3K; MAPK;
D O I
10.1046/j.1432-1033.2003.03446.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcription factor hypoxia inducible factor alpha-subunit (HIFalpha) is pivotal in the cellular response to the stress of hypoxia. Post-translational modification of HIFalpha by hydroxylase enzymes has recently been identified as a key 'oxygen sensing' mechanism within the cell. The absence of the substrate oxygen prevents the hydroxylases from modifying HIFalpha during hypoxia and allows dramatic up-regulation of both HIFalpha protein stability and transcriptional activation capability. In addition to this oxygen-dependent response, increased HIFalpha protein levels and/or enhanced transcriptional activity during normoxic conditions can be stimulated by various receptor-mediated factors such as growth-factors and cytokines (insulin, insulin-like growth factor 1 or 2, endothelial growth factor, tumour necrosis factor alpha, angiotensin-2). Oncogenes are also capable of HIFalpha activation. This induction is generally less intense than that stimulated by hypoxia and although not fully elucidated, appears to occur via hypoxia-independent, receptor-mediated signal pathways involving either phosphatidyl-inositol-3-kinase/Akt or mitogen activated protein kinase (MAPK) pathways, depending on the cell-type. Activation of Akt increases HIFalpha protein synthesis in the cell and results in increased HIFalpha protein and transcriptional activity. MAPK also activates HIFalpha protein synthesis and additionally may potentiate HIF1alpha transcriptional activity via a separate mechanism that does not necessarily require protein stabilization. Here we review the mechanisms and function of receptor-mediated signals in the multifaceted regulation of HIFalpha.
引用
收藏
页码:791 / 798
页数:8
相关论文
共 69 条
  • [1] Mersalyl is a novel inducer of vascular endothelial growth factor gene expression and hypoxia-inducible factor 1 activity
    Agani, F
    Semenza, GL
    [J]. MOLECULAR PHARMACOLOGY, 1998, 54 (05) : 749 - 754
  • [2] HIF-1 expression in healing wounds:: HIF-1α induction in primary inflammatory cells by TNF-α
    Albina, JE
    Mastrofrancesco, B
    Vessella, JA
    Louis, CA
    Henry, WL
    Reichner, JS
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2001, 281 (06): : C1971 - C1977
  • [3] Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1α
    Chan, DA
    Sutphin, PD
    Denko, NC
    Giaccia, AJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (42) : 40112 - 40117
  • [4] Gamma-ray bursts: Afterglows and central engines
    Cheng, KS
    Lu, T
    [J]. CHINESE JOURNAL OF ASTRONOMY AND ASTROPHYSICS, 2001, 1 (01): : 1 - 20
  • [5] EPAS1 trans-activation during hypoxia requires p42/p44 MAPK
    Conrad, PW
    Freeman, TL
    Beitner-Johnson, D
    Millhorn, DE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (47) : 33709 - 33713
  • [6] Placental-specific IGF-II is a major modulator of placental and fetal growth
    Constância, M
    Hemberger, M
    Hughes, J
    Dean, W
    Ferguson-Smith, A
    Fundele, R
    Stewart, F
    Kelsey, G
    Fowden, A
    Sibley, C
    Reik, W
    [J]. NATURE, 2002, 417 (6892) : 945 - 948
  • [7] Oncogenes in tumor metabolism, tumorigenesis, and apoptosis
    Dang, CV
    Lewis, BC
    Dolde, C
    Dang, G
    Shim, H
    [J]. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 1997, 29 (04) : 345 - 354
  • [8] C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
    Epstein, ACR
    Gleadle, JM
    McNeill, LA
    Hewitson, KS
    O'Rourke, J
    Mole, DR
    Mukherji, M
    Metzen, E
    Wilson, MI
    Dhanda, A
    Tian, YM
    Masson, N
    Hamilton, DL
    Jaakkola, P
    Barstead, R
    Hodgkin, J
    Maxwell, PH
    Pugh, CW
    Schofield, CJ
    Ratcliffe, PJ
    [J]. CELL, 2001, 107 (01) : 43 - 54
  • [9] Endothelial cell responses to hypoxic stress
    Faller, DV
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1999, 26 (01) : 74 - 84
  • [10] Feldser D, 1999, CANCER RES, V59, P3915